Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
see.ip - Details for PHARMAZEUTISCHE FORMULIERUNGEN ZUR BEHANDLUNG VON KRANKHEITEN, DIE DURCH KDM1A VERMITTELT WERDEN
Details for 2021876583
Up to date per 15.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2021876583
Title / Product Name
PHARMAZEUTISCHE FORMULIERUNGEN ZUR BEHANDLUNG VON KRANKHEITEN, DIE DURCH KDM1A VERMITTELT WERDEN
Status
Deleted
Protection Type
European Patent
(AT-) Application Number
2021876583
EP Publication Number
4221704
E-Number
1839853
Language
EN
PCT Number
US21053141
Publication Date
09.08.2023 A
24.09.2025 B1
Registration Date
24.09.2025
AT Publication Date
15.10.2025
Application Date
01.10.2021
Registration Number
-
Priorities
01.10.2020
US
202063086353 P
IPC
A61K 9/20 20060101AFI20250415BHEP
Maximum Duration of Protection
01.10.2041
Owner
Imago Biosciences Inc.
2729 Debbie Court
San Carlos, CA 94070
US
Representative
No representatives present
Inventor
TAPPER, Amy
San Carlos, California 94070
US
CELATKA, Cassandra
San Carlos, California 94070
US
SOULLIAC, Patricia
San Carlos, California 94070
US
VED, Parag
San Carlos, California 94070
US
VORA, Namrata
San Carlos, California 94070
US